Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The collagen receptor uparap in malignant mesothelioma: A potential diagnostic marker and therapeutic target

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prevalence of Pathogenic Germline DICER1 Variants in Young Individuals Thyroidectomised Due to Goitre - A National Danish Cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Extra-axial chordoma of the thumb: Report of a rare case with clinicopathologic and molecular analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalClinical Lung Cancer
Volume22
Issue number4
Pages (from-to)e528-e532
ISSN1525-7304
DOIs
Publication statusPublished - Jul 2021

    Research areas

  • Alectinib hepatotoxicity, ALK, CNS efficacy of brigatinib, CNS relapse, Dose-escalated brigatinib

ID: 61923785